Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées region (PharmacoMIP) network 2-year pilot study.
BACKGROUND
Spontaneous reporting of adverse drug reactions (ADRs) is fundamental to drug safety surveillance (pharmacovigilance); however, substantial under-reporting exists and is the main limitation of the system. Several factors could favour under-reporting.


OBJECTIVE
The aim of this pilot study was to assess the effect of regular visits of a Clinical Research Assistant (CRA) on the improvement of ADR reporting in non-university hospitals.


METHODS
We set up an ADR report collecting system that involved regular visits by a CRA to non-university hospitals, which was similar to a system that already existed in university hospitals in Toulouse, France. Two areas in our region were chosen: Haute Garonne and Gers. We compared firstly the reporting rate (number of reports/number of beds) of total ADRs (i.e. spontaneously reported ADRs plus solicited ADRs collected by the CRA) and secondly, the percentage of serious ADRs reported by non-university hospitals in these two areas, in 2005 (the year prior to CRA visits) and after the start of CRA visits (2006 until the end of December 2008). We also compared the reporting rate of total ADRs in Haute Garonne and Gers non-university hospitals with those reported during the same period with a control group (the Ariège area, which has a similar number of beds to Gers and that was not visited by the CRA). The characteristics of ADRs collected by the CRA were also described.


RESULTS
A total of 687 reports were collected by the CRA: 40% were classified as serious, including two deaths. The number of ADRs and the reporting rate increased significantly between 2005 and 2008 in non-university hospitals of Haute-Garonne and Gers, but not in Ariège. In Gers, the reporting rate was 3% in 2005 and 25% in 2008. In Haute-Garonne, the reporting rate was 11% in 2005 and 40% in 2008. The difference between the number of spontaneous and solicited reports also increased.


CONCLUSIONS
This study shows that regular visits by a CRA increases the number of ADRs collected by a Regional Pharmacovigilance Centre. Another interesting consequence was the rise in spontaneous reporting by healthcare professionals following the set-up of this system. Further assessment of this procedure is necessary for the long-term evaluation of its effectiveness.
Gony
Mireille
M
Service de Pharmacologie Clinique, Centre Midi-Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
Badie
Kattalin
K
Sommet
Agnès
A
Jacquot
Julien
J
Baudrin
Dominique
D
Gauthier
Pierre
P
Montastruc
Jean Louis
JL
Bagheri
Haleh
H
D016907:Adverse Drug Reaction Reporting Systems / Q000458:organization & administration; D005602:France; D006785:Hospitals, University / Q000458:organization & administration; D006801:Humans; D008137:Longitudinal Studies; D010865:Pilot Projects; D000078329:Workforce
BMJ. 2000 Apr 15;320(7241):1036
10764362
Lancet. 2003 Apr 19;361(9366):1347-8
12711472
Br J Clin Pharmacol. 1993 Jun;35(6):575-6
8329281
Br J Clin Pharmacol. 2003 Dec;56(6):658-63
14616426
Drug Saf. 2009;32(1):19-31
19132802
Drug Saf. 2003;26(14):1049-55
14583065
Drug Saf. 2009;32(1):77-83
19132807
Drug Saf. 2008;31(4):335-44
18366244
Med Care. 1999 Aug;37(8):809-14
10448723
Br J Clin Pharmacol. 1999 Oct;48(4):623-7
10583035
Drug Saf. 2007;30(11):1073-82
17973543
BMJ. 1990 Jan 6;300(6716):22-3
2105117
Br J Clin Pharmacol. 2008 May;65(5):793-4
18279475
Br J Clin Pharmacol. 1991 Feb;31(2):188-9
2049237
Drug Saf. 2005;28(9):825-33
16119975
Eur J Clin Pharmacol. 2007 Jun;63(6):613-8
17404719
Drug Saf. 2006;29(4):331-40
16569082
Therapie. 1985 Mar-Apr;40(2):111-8
4002188
BMJ. 2004 Jul 3;329(7456):15-9
15231615
Eur J Clin Pharmacol. 2009 Jan;65(1):43-6
18825377
Therapie. 1995 Sep-Oct;50(5):455-8
8571285
Lancet. 2000 Oct 7;356(9237):1255-9
11072960
Eur J Clin Pharmacol. 2006 May;62(5):381-5
16572320